Sarepta Therapeutics (SRPT) receives a stop-work order for its Ebola virus therapeutics from the...


Sarepta Therapeutics (SRPT) receives a stop-work order for its Ebola virus therapeutics from the U.S. Department of Defense due to budget constraints. The order will remain in effect until September 1, when a final decision will be made on the ultimate future of the program. Shares -3.2% AH.

From other sites
Comments (1)
  • aikifredicist
    , contributor
    Comment (1) | Send Message
     
    DoD spending cutbacks zap another program...
    4 Aug 2012, 04:01 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs